髋部骨折超声引导区域麻醉的成本节约分析:概率成本-效用分析
本研究为10000次迭代的概率蒙特卡洛成本-效用模型,比较区域麻醉联合常规护理与单纯常规护理在≥65岁美国髋部骨折患者中90天医院视角的成本效果。区域麻醉占优,每例平均节省7826美元(95%CrI 3490-13311),QALY增益0.0028(95%CrI 0.000687-0.005751),主要来自住院缩短(5.97 vs 6.96天)、出院至专业护理机构概率降低(55.4% vs 60.0%)及谵妄发生率降低(25.2% vs 35.0%;RR 0.72)。在120000美元/QALY阈值下成本效益概率接近100.0%,结果在所有敏感性分析中稳健。
要点
- 对≥65岁美国髋部骨折患者,区域麻醉联合常规护理90天内每例平均节省7826美元(95%CrI 3490-13311),并获QALY增益0.0028。
- 区域麻醉组住院天数5.97天 vs 常规护理6.96天,出院至专业护理机构概率55.4% vs 60.0%,出院者机构天数19.9 vs 23.9天。
- 谵妄发生率区域麻醉组25.2% vs 常规护理35.0%(RR 0.72),谵妄相关费用贡献额外节省。
- 按2025 AHA/ACC推荐120000美元/QALY阈值,区域麻醉成本效益概率接近100.0%,所有敏感性分析结果稳健。
适用人群与场景
- 美国≥65岁髋部骨折成人,90天医院视角;模型比较区域麻醉联合常规护理与单纯常规护理。
诊断标准与关键阈值
- 成本效益阈值采用2025 AHA/ACC推荐的120000美元/QALY。
处置流程与药物剂量
- 原文未提及具体区域麻醉药物、剂量、给药途径、频次或疗程。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:10000次迭代概率蒙特卡洛成本-效用模型;人群:美国≥65岁髋部骨折成人,90天医院视角;干预:区域麻醉联合常规护理 vs 单纯常规护理。
- 主要终点:区域麻醉占优,每例平均节省7826美元(95%CrI 3490-13311),QALY增益0.0028(95%CrI 0.000687-0.005751)。
- 关键次要终点:住院5.97 vs 6.96天;出院至专业护理机构概率55.4% vs 60.0%;出院者机构天数19.9 vs 23.9天;谵妄发生率25.2% vs 35.0%(RR 0.72)。
证据类型、等级与局限
- 证据类型:概率成本-效用模型(基于临床试验、系统评价和美国成本数据);局限:模型预测而非前瞻性RCT,成本与效果参数依赖外部输入,需前瞻性验证。
对床旁实践的改变
- 对≥65岁髋部骨折患者,区域麻醉联合常规护理可节约成本并轻微改善QALY,支持将其纳入标准髋部骨折护理路径。
- 模型结果基于美国90天医院视角和120000美元/QALY阈值,不直接推广至其他医疗体系或非髋部骨折人群。
指南或共识出处
- 2025 AHA/ACC推荐的成本效益阈值120000美元/QALY。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
STUDY OBJECTIVE: Despite evidence that regional anesthesia (RA) improves outcomes in older adults with hip fracture, adoption remains variable, and cost-effectiveness in U.S. settings is unknown. This study evaluated the cost-effectiveness of RA versus usual care using a probabilistic Monte Carlo cost-utility model.
METHODS: A 10,000-iteration probabilistic Monte Carlo cost-utility model compared RA plus usual care to usual care alone for U.S. adults aged ≥65 years with hip fracture over a 90-day hospital perspective. Inputs were derived from clinical trials, systematic reviews, and U.S. cost data. Primary outcomes were total costs and quality-adjusted life-years (QALYs); secondary outcomes included delirium rates, length of stay, opioid use, and discharge disposition. Cost-effectiveness was assessed at a $120,000/QALY threshold per 2025 AHA/ACC recommendations.
RESULTS: RA dominated usual care, yielding mean cost savings of $7826 per patient (95% credible interval [CrI]: 3490 to 13,311) and a QALY gain of 0.0028 (95% CrI: 0.000687 to 0.005751). Savings were driven by shorter hospitalization (5.97 vs. 6.96 days), lower probability of skilled nursing facility discharge (55.4% vs. 60.0%), and fewer facility days among those discharged (19.9 vs. 23.9 days). Delirium-related costs contributed additional savings, reflecting lower delirium incidence (25.2% vs. 35.0%; RR 0.72). The probability of cost-effectiveness was near 100.0% at $120,000/QALY. Extrapolated to the reported 52.9% national adoption rate (∼158,700 patients annually), estimated U.S. savings are $1.24 billion with 449 QALYs gained. Results were robust across all sensitivity analyses.
CONCLUSION: RA for older adults with hip fracture was cost-saving and improved quality-adjusted outcomes. These findings provide an economic rationale for incorporating regional anesthesia into standard hip fracture care pathways in U.S.
参考来源
- Shokoohi H, Danesh E, Schulwolf S, et al. Cost-saving analysis of ultrasound-guided regional anesthesia for hip fractures: A probabilistic cost-utility analysis. Am J Emerg Med. 2026. PMID: 42826623. doi:10.1016/j.ajem.2026.09.040
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。